These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6073297)

  • 41. Red-cell suspensions.
    Sherwood GK; Levine P; Cedarbaum A; Janes AW; Valigorsky JM; Lloyd HE; Hinrichs HR; Page PL; Rappeport JM; Yunis EJ; Stocks JF; Surgenor DM
    N Engl J Med; 1979 Apr; 300(17):984-5. PubMed ID: 431571
    [No Abstract]   [Full Text] [Related]  

  • 42. Advances in erythrocyte preservation and hemoglobin substitutes.
    Goodrich RP; Sowemino-Coker SO; Weinstein R
    Curr Opin Hematol; 1994 Mar; 1(2):162-9. PubMed ID: 9371276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methods for preparation of suspensions of buffy coat-poor red blood cells for transfusion; including a report of 50 transfusions of suspensions of buffy coat-poor red blood cells prepared by a dextran sedimentation method.
    CHAPLIN H; BRITTINGHAM TE; CASSELL M
    Am J Clin Pathol; 1959 May; 31(5):373-83. PubMed ID: 13649627
    [No Abstract]   [Full Text] [Related]  

  • 44. [Results of the development of the problem of blood substitutes in the USSR].
    Grozdov DM
    Probl Gematol Pereliv Krovi; 1973 Dec; 17(12):8-14. PubMed ID: 4582536
    [No Abstract]   [Full Text] [Related]  

  • 45. [Modezhel' erythrocyte preservative as an experimental and clinical blood substitute].
    Selivanov EA; Mel'nikova VN; Kochetygov NI; Pleshakov VT; Gerbut KA; Krivtsova IM; Lur'e GO
    Vestn Khir Im I I Grek; 1996; (1):71-4. PubMed ID: 8753967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [ON THE FORMATION OF AGGREGATES IN ACD-PRESERVED BLOOD].
    KUENZEL HP; HIRSCH H
    Acta Haematol; 1964 Aug; 32():89-99. PubMed ID: 14224719
    [No Abstract]   [Full Text] [Related]  

  • 47. [Studies on dry plasma stored for a period of 4 years].
    Tesar V
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(2):209-14. PubMed ID: 4168345
    [No Abstract]   [Full Text] [Related]  

  • 48. [Erythrocyte sediments as a volume substitute in surgery].
    Wiesner HR; Schwarz H; Frey-Wettstein M
    Helv Chir Acta; 1975 Mar; 42(1-2):97-100. PubMed ID: 1133063
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effect of various plasma substitutes on a change in proton affinity for the erythrocytes in thermal exposure].
    Bogomolova LG; Gromov AE; Znamenskaia TV; Rozengart VI
    Probl Gematol Pereliv Krovi; 1978 Mar; 23(3):55-7. PubMed ID: 25432
    [No Abstract]   [Full Text] [Related]  

  • 50. [Full blood preservation or erythrocyte concentrate].
    Seidl S
    Dtsch Med Wochenschr; 1977 Apr; 102(17):669-70. PubMed ID: 852427
    [No Abstract]   [Full Text] [Related]  

  • 51. Red-cell suspensions.
    Diamond LK
    N Engl J Med; 1979 Apr; 300(17):984. PubMed ID: 431570
    [No Abstract]   [Full Text] [Related]  

  • 52. [Study of the effect of glass quality on bidistilled water stored for a long time and used for solving dry blood preparations and blood substitutes].
    Manueva GN
    Probl Gematol Pereliv Krovi; 1969 Sep; 14(9):58-60. PubMed ID: 5376284
    [No Abstract]   [Full Text] [Related]  

  • 53. [Present status of the artificial blood].
    Hori M
    Geka Chiryo; 1969 Sep; 21(3):341-7. PubMed ID: 4901807
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparative assessment of functional properties of erythrocytes of various hemotransfusion media].
    Mel'nikova VN; Mikhnovich EP; Kuz'min VA; Gusev VP
    Probl Gematol Pereliv Krovi; 1977 Jun; 22(6):11-7. PubMed ID: 877044
    [No Abstract]   [Full Text] [Related]  

  • 55. [Initial experience with the clinical use of an erythrocyte mass resuspended and preserved in an Eritronaf solution].
    Agranenko VA; Suvorova IA; Zorenko VIu; Golubeva VL; Cherniakhovskiĭ FR
    Gematol Transfuziol; 1988 Jun; 33(6):7-12. PubMed ID: 3169521
    [No Abstract]   [Full Text] [Related]  

  • 56. [Biochemical modification of an erythrocyte mass having lost its effectiveness after an extremely long storage time].
    Tibilova NN; Markova NA; Ermol'chuk ON; Platonova OV; Agranenko VA
    Gematol Transfuziol; 1988 Jun; 33(6):12-4. PubMed ID: 3169510
    [No Abstract]   [Full Text] [Related]  

  • 57. [A method of erythrocyte cryopreservation with a 20% glycerin content in the cryoprotective solution].
    Mel'nikova VN; Nedel'skiĭ GT; Kuz'min VA; Platonova GG
    Probl Gematol Pereliv Krovi; 1981 Jun; 26(6):9-11. PubMed ID: 7279888
    [No Abstract]   [Full Text] [Related]  

  • 58. [USE OF PLASTIC BAGS FOR THE PREPARATION AND PRESERVATION OF BLOOD COMPONENTS].
    TEODOROVICH VI; SHULUTKO LC
    Probl Gematol Pereliv Krovi; 1963 Sep; 8():32-4. PubMed ID: 14119761
    [No Abstract]   [Full Text] [Related]  

  • 59. [Improved method of obtaining a leukocyte suspension for component blood transfusion therapy].
    Volkova SD; Kuz'min VA; Mel'nikova VN; Platonova GG; Shulutko LS
    Probl Gematol Pereliv Krovi; 1981 Dec; 26(12):43-6. PubMed ID: 7329958
    [No Abstract]   [Full Text] [Related]  

  • 60. [Suggestions for the surgeons concerning the use of blood substitutes].
    Filatov AN
    Vestn Khir Im I I Grek; 1973 Nov; 111(11):136-40. PubMed ID: 4776323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.